Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC

NCT02343952

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Fort Wayne Oncology & Hematology, Inc. Fort Wayne, Indiana, United States
  • IU Health Goshen Hospital Goshen, Indiana, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View all 15 locations
View Trial Details
Completed

M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

NCT03840915

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Compassionate Care Research Group Inc - Edinger Medical Group, Inc. Fountain Valley, California, United States
  • California Cancer Associates for Research & Excellence, Inc. San Marcos, California, United States
  • Hematology - Oncology Associates of Treasure Coast - Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
  • Baptist Health Lexington Oncology Associates Lexington, Kentucky, United States
View all 19 locations
View Trial Details
Completed

Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil

NCT04947683

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
Locations
  • Centro Regional Integrado de Oncologia (CRIO) Fortaleza, Ceará, Brazil
  • Instituto D'OR Rio de Janeiro, Brazil
  • Liga Norte Riograndense Contra o Câncer Natal, Rio Grande do Norte, Brazil
  • CPO Pucrs Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details
Completed

French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings

NCT01700582

Conditions
ALK Gene Mutation, BRAF Gene Mutation, Bronchial Neoplasms, +10 more
Locations
  • Clinique Calabet - Centre de Radiothérapie et d'Oncologie Agen, France
  • Clinique Claude Bernard Albi, France
  • Clinique de l'Europe Amiens, France
  • CHU d'Angers Angers, France
View all 133 locations
View Trial Details
Completed

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

NCT04452214

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +28 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Hospital of The University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)

NCT03345810

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Gesundheitszentrum St. Marien GmbH Amberg, Germany
  • Ev. Lungenklinik Berlin Berlin, Germany
  • Kliniken der Stadt Köln gGmbH Cologne, Germany
  • Klinikum Darmstadt Darmstadt, Germany
View all 30 locations
View Trial Details
Completed

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

NCT03102242

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • EMMC Cancer Care Brewer, Maine, United States
View all 13 locations
View Trial Details
Completed

G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer

NCT03455829

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • UCLA Medical Center, Division of Hematology/Oncology/Clinical Research Unit Santa Monica, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
  • Sylvester Comprehensive Cancer Center/University of Miami Miller School of Medicine Fox Building, Suite 200 G Miami, Florida, United States
View Trial Details

Related conditions